Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 3 studies | 35% ± 20% | |
GABAergic neuron | 3 studies | 34% ± 15% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 36% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1114.73 | 2637 / 2642 | 99% | 5.74 | 698 / 705 |
prostate | 100% | 1158.56 | 245 / 245 | 96% | 3.15 | 481 / 502 |
pancreas | 100% | 1084.05 | 328 / 328 | 88% | 1.97 | 156 / 178 |
thymus | 100% | 926.48 | 653 / 653 | 85% | 1.88 | 514 / 605 |
kidney | 100% | 701.70 | 89 / 89 | 84% | 2.38 | 757 / 901 |
stomach | 100% | 750.88 | 359 / 359 | 83% | 1.95 | 237 / 286 |
skin | 100% | 532.17 | 1800 / 1809 | 83% | 2.38 | 390 / 472 |
ovary | 100% | 813.69 | 180 / 180 | 81% | 2.23 | 347 / 430 |
adrenal gland | 100% | 1305.04 | 258 / 258 | 80% | 2.79 | 184 / 230 |
intestine | 100% | 883.67 | 966 / 966 | 79% | 1.58 | 417 / 527 |
esophagus | 99% | 721.80 | 1437 / 1445 | 70% | 1.73 | 128 / 183 |
lung | 99% | 632.48 | 574 / 578 | 65% | 1.42 | 755 / 1155 |
bladder | 100% | 1204.43 | 21 / 21 | 63% | 1.33 | 320 / 504 |
breast | 100% | 672.04 | 459 / 459 | 58% | 1.41 | 647 / 1118 |
uterus | 100% | 1210.13 | 170 / 170 | 45% | 1.12 | 207 / 459 |
liver | 99% | 511.03 | 224 / 226 | 25% | 0.52 | 100 / 406 |
spleen | 100% | 1276.17 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 981.04 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 626.93 | 1200 / 1204 | 0% | 0 | 0 / 0 |
heart | 95% | 329.59 | 815 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 74% | 1.49 | 59 / 80 |
peripheral blood | 70% | 336.17 | 654 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 59% | 1.10 | 17 / 29 |
muscle | 33% | 61.59 | 263 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 27% | 0.48 | 12 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0070585 | Biological process | protein localization to mitochondrion |
GO_0009749 | Biological process | response to glucose |
GO_0048814 | Biological process | regulation of dendrite morphogenesis |
GO_0045087 | Biological process | innate immune response |
GO_0007165 | Biological process | signal transduction |
GO_0048678 | Biological process | response to axon injury |
GO_0043523 | Biological process | regulation of neuron apoptotic process |
GO_0019677 | Biological process | NAD catabolic process |
GO_0030154 | Biological process | cell differentiation |
GO_0050877 | Biological process | nervous system process |
GO_0007399 | Biological process | nervous system development |
GO_0034128 | Biological process | negative regulation of MyD88-independent toll-like receptor signaling pathway |
GO_0005874 | Cellular component | microtubule |
GO_0005739 | Cellular component | mitochondrion |
GO_0032991 | Cellular component | protein-containing complex |
GO_0030425 | Cellular component | dendrite |
GO_0009986 | Cellular component | cell surface |
GO_0005829 | Cellular component | cytosol |
GO_0045202 | Cellular component | synapse |
GO_0005737 | Cellular component | cytoplasm |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0030424 | Cellular component | axon |
GO_0003953 | Molecular function | NAD+ nucleosidase activity |
GO_0050135 | Molecular function | NADP+ nucleosidase activity |
GO_0035591 | Molecular function | signaling adaptor activity |
GO_0005515 | Molecular function | protein binding |
GO_0061809 | Molecular function | NAD+ nucleotidase, cyclic ADP-ribose generating |
Gene name | SARM1 |
Protein name | NAD(+) hydrolase SARM1 (NADase SARM1) (hSARM1) (EC 3.2.2.6) (NADP(+) hydrolase SARM1) (EC 3.2.2.-) (Sterile alpha and Armadillo repeat protein) (Sterile alpha and TIR motif-containing protein 1) (Sterile alpha motif domain-containing protein 2) (MyD88-5) (SAM domain-containing protein 2) (Tir-1 homolog) (HsTIR) NAD(+) hydrolase SARM1 (EC 3.2.2.6) (NADP(+) hydrolase SARM1) (Sterile alpha and TIR motif-containing protein 1) NAD(+) hydrolase SARM1 (NADP(+) hydrolase SARM1) (Sterile alpha and TIR motif-containing protein 1) Sterile alpha and TIR motif containing 1 |
Synonyms | KIAA0524 SAMD2 SARM |
Description | FUNCTION: NAD(+) hydrolase, which plays a key role in axonal degeneration following injury by regulating NAD(+) metabolism . Acts as a negative regulator of MYD88- and TRIF-dependent toll-like receptor signaling pathway by promoting Wallerian degeneration, an injury-induced form of programmed subcellular death which involves degeneration of an axon distal to the injury site . Wallerian degeneration is triggered by NAD(+) depletion: in response to injury, SARM1 is activated and catalyzes cleavage of NAD(+) into ADP-D-ribose (ADPR), cyclic ADPR (cADPR) and nicotinamide; NAD(+) cleavage promoting cytoskeletal degradation and axon destruction . Also able to hydrolyze NADP(+), but not other NAD(+)-related molecules . Can activate neuronal cell death in response to stress . Regulates dendritic arborization through the MAPK4-JNK pathway (By similarity). Involved in innate immune response: inhibits both TICAM1/TRIF- and MYD88-dependent activation of JUN/AP-1, TRIF-dependent activation of NF-kappa-B and IRF3, and the phosphorylation of MAPK14/p38 . . |
Accessions | J3QRE0 ENST00000585482.6 [Q6SZW1-1] Q6SZW1 J3KRZ6 Q05B42 ENST00000582323.1 J3KSG7 ENST00000578128.5 ENST00000579593.1 Q0D2N8 |